EUVIMEDEUVIMED entdecken
Open Access

CSF1‐R inhibition attenuates posttraumatic osteoarthritis and quadriceps atrophy following ligament injury

Alexander R Keeble iD, Nicholas T Thomas iD, Peyton J Balawender, Camille R Brightwell, Sara Gonzalez-Velez iD, Madeline G O'Daniel, Caitlin E Conley, Austin V Stone, Darren L Johnson, Brian Noehren iD, Cale A Jacobs, Christopher S Fry iD und 1 weitere

The Journal of Physiology · 2025

DOI: 10.1113/jp286815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physiology, 2025. Verfasst von Alexander R Keeble und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Muscle Biology, University of Kentucky, Lexington, KY, USA. Hauptthemen laut MEDLINE: Anterior Cruciate Ligament Injuries, Quadriceps Muscle, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, Osteoarthritis, Knee. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Knee osteoarthritis contributes substantially to worldwide disability. Post‐traumatic osteoarthritis (PTOA) develops secondary to joint injury, such as ligament rupture, and there is increasing evidence suggesting a key role for inflammation in the aetiology of PTOA and associated functional deficits. Colony stimulating factor 1 receptor (CSF1‐R) has been implicated in the pathogenesis of musculoskeletal degeneration following anterior cruciate ligament (ACL) injury. We sought to assess the efficacy of CSF1‐R inhibition to mitigate muscle and joint pathology in a mouse model of PTOA. Four‐month‐old mice were randomized to receive a CSF1‐R inhibitor and studied for 7 or 28 days after joint injury. Additionally, we profiled synovial fluid samples for CSF1‐R from patients with injury to their ACL. Transcriptomic analysis of quadriceps muscle and articular cartilage in CSF1‐R inhibitor‐treated animals at 7 days after injury revealed elevated chondrocyte differentiation within articular cartilage and enhanced metabolic and contractile gene expression within skeletal muscle. At 28 days post‐injury, CSF1‐R inhibition attenuated PTOA severity and mitigated skeletal muscle atrophy. Patient synovial fluid CSF1‐R levels correlated with matrix metalloproteinase 13, a prognostic marker and molecular effector of PTOA. Our findings support an opportunity for CSF1‐R targeting to mitigate the severity of PTOA and muscle atrophy after joint injury. image Key points Posttraumatic osteoarthritis (PTOA) of the knee commonly results from direct injury to the joint, which is characterized by pain, weakness, and disability. Induction of colony stimulating factor one receptor (CSF1‐R) is positively associated with knee trauma severity, and the initial acute inflammatory state suppresses muscle recovery and degrades articular cartilage. Skeletal muscle and articular cartilage transcriptomic response following direct joint injury in a murine model of PTOA is rescued by pharmacological inhibition of CSF1‐R. CSF1‐R inhibition mitigated skeletal muscle atrophy and attenuated PTOA severity and synovitis. Patient synovial fluid CSF1‐R levels correlated with matrix metalloproteinase 13, a prognostic marker and molecular effector of PTOA, offering further evidence for CSF1‐R as a therapeutic target across musculoskeletal tissues after injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anterior Cruciate Ligament InjuriesQuadriceps MuscleReceptors, Granulocyte-Macrophage Colony-Stimulating FactorOsteoarthritis, KneeMuscular AtrophyAnimalsMiceMaleHumansMice, Inbred C57BLFemaleSynovial FluidCartilage, Articular

Stichwörter der Autor:innen

anterior cruciate ligamentcartilageinflammationskeletal muscle

Substanzen

Receptors, Granulocyte-Macrophage Colony-Stimulating FactorCsf1r protein, mouse

Autor:innen und Institutionen

  • Center for Muscle Biology, University of Kentucky, Lexington, KY, USA.
  • Department of Physiology, College of Medicine, University of Kentucky, Lexington, KY, USA.
  • Department of Athletic Training and Clinical Nutrition, College of Health Sciences, University of Kentucky, Lexington, KY, USA.
  • Department of Orthopaedic Surgery and Sports Medicine, College of Medicine, University of Kentucky, Lexington, KY, USA.
  • Department of Physical Therapy, College of Health Sciences, University of Kentucky, Lexington, KY, USA.
  • Mass General Brigham Sports Medicine, Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Alexander R Keeble, Nicholas T Thomas, Sara Gonzalez-Velez, Brian Noehren, Christopher S Fry, Allison M Owen

Förderung

  • NIAMS NIH HHS

Zitieren

APA

Keeble, A. R., Thomas, N. T., Balawender, P. J., Brightwell, C. R., Gonzalez-Velez, S., O'Daniel, M. G., Conley, C. E., Stone, A. V., Johnson, D. L., Noehren, B., Jacobs, C. A., Fry, C. S., & Owen, A. M. (2025). CSF1‐R inhibition attenuates posttraumatic osteoarthritis and quadriceps atrophy following ligament injury. The Journal of Physiology. https://doi.org/10.1113/jp286815

Vancouver

Keeble AR, Thomas NT, Balawender PJ, Brightwell CR, Gonzalez-Velez S, O'Daniel MG, et al. CSF1‐R inhibition attenuates posttraumatic osteoarthritis and quadriceps atrophy following ligament injury. The Journal of Physiology. 2025. doi:10.1113/jp286815

BibTeX
@article{Keeble2025,
  author = {Keeble, Alexander R and Thomas, Nicholas T and Balawender, Peyton J and Brightwell, Camille R and Gonzalez-Velez, Sara and O'Daniel, Madeline G and Conley, Caitlin E and Stone, Austin V and Johnson, Darren L and Noehren, Brian and Jacobs, Cale A and Fry, Christopher S and Owen, Allison M},
  title = {CSF1‐R inhibition attenuates posttraumatic osteoarthritis and quadriceps atrophy following ligament injury},
  journal = {The Journal of Physiology},
  year = {2025},
  doi = {10.1113/jp286815}
}
Kostenlos starten →